L&C Bio Co., Ltd

KOSDAQ 290650.KQ

L&C Bio Co., Ltd Return on Assets (ROA) for the year ending December 31, 2023: 18.44%

L&C Bio Co., Ltd Return on Assets (ROA) is 18.44% for the year ending December 31, 2023, a 710.57% change year over year. Return on assets measures profitability against assets; higher ROA indicates efficient asset use and profitability.

L&C Bio Co., Ltd Return on Assets (ROA) for the year ending December 31, 2022 was 2.28%, a -82.31% change year over year.
L&C Bio Co., Ltd Return on Assets (ROA) for the year ending December 31, 2021 was 12.86%, a -4.15% change year over year.
L&C Bio Co., Ltd Return on Assets (ROA) for the year ending December 31, 2020 was 13.42%, a 22.58% change year over year.
L&C Bio Co., Ltd Return on Assets (ROA) for the year ending December 31, 2019 was 10.95%, a 20.62% change year over year.

Key data

Date	Return on Assets (ROA)	Return on Equity (ROE)	Return on Capital Employed (ROCE)	Interest Coverage Ratio

KOSDAQ: 290650.KQ

L&C Bio Co., Ltd

CEO	Mr. Chul Lee Whan
IPO Date	Nov. 1, 2018
Location	South Korea
Headquarters	Suntechcity
Employees	122
Sector	Health Care
Industries Biotechnology Cosmetics Pharmaceuticals Research & Consulting

Description

L&C BIO Co., Ltd. operates as a research and development company in tissue regeneration medicine. It offers human tissue, medical device, and cosmetics products. The company was founded in 2011 and is headquartered in Seongnam, South Korea.

Key trends

Past 5 years